Publications by authors named "B Polsky"
Article Synopsis
- This study evaluates the effectiveness of monoclonal antibodies (mAbs) in treating outpatients with COVID-19 to provide more clinical data for their use.
- Conducted at multiple campuses in New York, the study compared 1,344 mAb-treated patients with 1,344 patients who did not receive mAb therapy, assessing outcomes like emergency visits and hospital admissions within 30 days.
- Results showed that mAb therapy significantly reduced the likelihood of emergency department visits (7.5% vs. 12.3%) and inpatient admissions (5.9% vs. 11.6%), indicating its potential benefits for outpatient COVID-19 treatment.
Objective: To describe the experience of COVID-19 disease among chronically ventilated and nonventilated nursing home patients living in 3 separate nursing homes.
Design: Observational study of death, respiratory illness and COVID-19 polymerase chain reaction (PCR) results among residents and staff during nursing home outbreaks in 2020.
Setting And Participants: 93 chronically ventilated nursing home patients and 1151 nonventilated patients living among 3 separate nursing homes on Long Island, New York, as of March 15, 2020.
Suppression of HIV replication by antiretroviral therapy (ART) or host immunity can prevent AIDS but not other HIV-associated conditions including neurocognitive impairment (HIV-NCI). Pathogenesis in HIV-suppressed individuals has been attributed to reservoirs of latent-inducible virus in resting CD4+ T cells. Macrophages are persistently infected with HIV but their role as HIV reservoirs in vivo has not been fully explored.
View Article and Find Full Text PDFArticle Synopsis
- Catheter-related bloodstream infections (CRBSI) are serious complications for patients needing long-term vascular catheters, prompting the need for effective antimicrobial treatments.
- Taurolidine, an antimicrobial agent, is the active component in Neutrolin®, a recently introduced catheter lock solution that has shown potential in preventing infections.
- A study involving 201 patients over two years reported low CRBSI rates and no major side effects from Neutrolin®, suggesting its effectiveness when combined with proper catheter care.